Well its OK to hope, but belief without scientific proof is liable to lead to disappointment.
So far for indications such as heart failure and spinal disc healing the goal posts have shifted to post hoc analysis of surrogate end points and softer targets such "reduced GI bleeding" and "reduced back pain", and the number of patients in the trials required to show statistical significance has increased.
Evidence so far of efficacy is relatively weak and inconsistent, that's why the FDA is being cautious
MSB Trading 2020 - a new dawn, page-8368
-
- There are more pages in this discussion • 4,703 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.5¢ |
Change
-0.040(3.90%) |
Mkt cap ! $1.127B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 97.0¢ | $6.007M | 5.990M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 37905 | 98.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 62603 | 19 |
View Market Depth
| Last trade - 13.55pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |